EBITDA
-$704.00M
Quarterly · Period ending: · USD
MRNA EBITDA
Latest reported-$704.00Mperiod ending
Latest reported-$704.00Mperiod ending
MRNA Quarterly EBITDA (-$75.08M → -$704.00M)
Quarterly EBITDA
High-resolution chart · PNG
MRNA ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -704,000,000 | |
| -1,258,000,000 | |
| -732,000,000 | |
| -135,000,000 | |
| -760,000,000 | |
| -924,000,000 | |
| -1,118,000,000 | |
| 79,000,000 | |
| -1,232,000,000 | |
| -1,123,000,000 | |
| 278,000,000 | |
| -1,699,000,000 | |
| -1,644,000,000 | |
| -218,000,000 | |
| 1,745,000,000 | |
| 1,338,000,000 | |
| 2,555,000,000 | |
| 4,306,000,000 | |
| 5,488,000,000 | |
| 3,626,000,000 | |
| 3,137,000,000 | |
| 1,278,000,000 | |
| -259,798,000 | |
| -221,438,000 | |
| -106,687,000 | |
| -115,049,000 | |
| -113,475,000 | |
| -114,529,000 | |
| -126,337,000 | |
| -123,820,000 | |
| -132,383,000 | |
| -73,850,000 | |
| -84,592,000 | |
| -67,196,000 | |
| -35,913,000 | |
| -62,740,000 | |
| -75,083,000 | |
| -75,083,000 |